{"nctId":"NCT00251927","briefTitle":"Esomeprazole (NEXIUM) vs. Surgery","startDateStruct":{"date":"2001-10"},"conditions":["Gastroesophageal Reflux"],"count":626,"armGroups":[{"label":"1","type":"ACTIVE_COMPARATOR","interventionNames":["Procedure: Laparoscopic fundoplication (surgery)"]},{"label":"2","type":"EXPERIMENTAL","interventionNames":["Drug: esomeprazole"]}],"interventions":[{"name":"esomeprazole","otherNames":["NexiumÂ®"]},{"name":"Laparoscopic fundoplication (surgery)","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Subjects considered suitable for surgical treatment and long-term management of esomeprazole.\n* History of chronic reflux esophagitis or symptomatic GERD\n\nExclusion Criteria:\n\n* History of esophageal, gastric, or duodenal surgery predicted to influence negatively on subsequent treatment within the study.\n* Contraindication to the study drug.\n* Pregnancy, lactating or of child-bearing potential.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"70 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants With Treatment Failure at 5 Years","description":"Treatment failure in the surgical arm defined when need for medical treatment for control of symptoms from reflux disease. Treatment failure in the medical arm defined when need for treatment other than esomeprazole for control of symptoms of reflux disease.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"33","spread":null},{"groupId":"OG001","value":"19","spread":null}]}]}]},{"type":"SECONDARY","title":"Los Angeles (LA) Grade 'Normal' at 5 Year Visit","description":"Endoscopic findings classified according to the Los Angeles classification:\n\nGrade Normal - endoscopy reveals no mucosal break Grade A- one or more mucosal breaks \\<5 mm in maximal length Grade B - one or more mucosal breaks \\>5 mm, but without continuity across mucosal folds Grade C - Mucosal breaks continuous between \\>2 mucosal folds, but involving less than 75% of the esophageal circumference Grade D - Mucosal breaks involving more than 75% of the esophageal circumference","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"144","spread":null},{"groupId":"OG001","value":"158","spread":null}]}]}]},{"type":"SECONDARY","title":"Investigator-assessed Heartburn Severity at 5 Year Visit, Participants With no Heartburn","description":"Presence of heartburn assessed retrospectively by the investigator. Classified by severity (none, mild, moderate, severe) Participants with no heartburn","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"163","spread":null},{"groupId":"OG001","value":"161","spread":null}]}]}]},{"type":"SECONDARY","title":"Total Score for Microscopic Reflux-related Changes in the Distal Esophagus 2 cm Above the Z-line, at 5 Year Visit","description":"The total score expressed as a mean of all the scores/number of lesions assessed; scored 2 when erosion/necrosis is found. The score could range from 0 to 2 (maximum severity). Only participants with biopsy at 5 years visit included","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.23","spread":"0.10"},{"groupId":"OG001","value":"0.25","spread":"0.03"}]}]}]},{"type":"SECONDARY","title":"Percentage Time With pH<4 During 24-hour pH Metry at 5 Year Visit","description":"Intra-gastric acid exposures assessed by 24-h pH-metry. Only participants with pH-emtry performed at 5 year visit included","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.9","spread":"7.0"},{"groupId":"OG001","value":"4.7","spread":"7.0"}]}]}]},{"type":"SECONDARY","title":"Los Angeles (LA) Grade 'A' at 5 Year Visit","description":"Endoscopic findings classified according to the Los Angeles classification:\n\nGrade Normal - endoscopy reveals no mucosal break Grade A- one or more mucosal breaks \\<5 mm in maximal length Grade B - one or more mucosal breaks \\>5 mm, but without continuity across mucosal folds Grade C - Mucosal breaks continuous between \\>2 mucosal folds, but involving less than 75% of the esophageal circumference Grade D - Mucosal breaks involving more than 75% of the esophageal circumference","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"12","spread":null},{"groupId":"OG001","value":"16","spread":null}]}]}]},{"type":"SECONDARY","title":"Los Angeles (LA) Grade 'B' at 5 Year Visit","description":"Endoscopic findings classified according to the Los Angeles classification:\n\nGrade Normal - endoscopy reveals no mucosal break Grade A- one or more mucosal breaks \\<5 mm in maximal length Grade B - one or more mucosal breaks \\>5 mm, but without continuity across mucosal folds Grade C - Mucosal breaks continuous between \\>2 mucosal folds, but involving less than 75% of the esophageal circumference Grade D - Mucosal breaks involving more than 75% of the esophageal circumference","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"7","spread":null}]}]}]},{"type":"SECONDARY","title":"Los Angeles (LA) Grade C at 5 Year Visit","description":"Endoscopic findings classified according to the Los Angeles classification:\n\nGrade Normal - endoscopy reveals no mucosal break Grade A- one or more mucosal breaks \\<5 mm in maximal length Grade B - one or more mucosal breaks \\>5 mm, but without continuity across mucosal folds Grade C - Mucosal breaks continuous between \\>2 mucosal folds, but involving less than 75% of the esophageal circumference Grade D - Mucosal breaks involving more than 75% of the esophageal circumference","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]}]},{"type":"SECONDARY","title":"Investigator-assessed Heartburn Severity at 5 Year Visit, Participants With Mild Heartburn","description":"Presence of heartburn assessed retrospectively by the investigator. Classified by severity (none, mild, moderate, severe). Participants with mild heartburn","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"11","spread":null},{"groupId":"OG001","value":"25","spread":null}]}]}]},{"type":"SECONDARY","title":"Investigator-assessed Heartburn Severity at 5 Year Visit, Participants With Moderate Heartburn","description":"Presence of heartburn assessed retrospectively by the investigator. Classified by severity (none, mild, moderate, severe). Participants with moderate heartburn","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]}]},{"type":"SECONDARY","title":"Investigator-assessed Heartburn Severity at 5 Year Visit, Participants With Severe Heartburn","description":"Presence of heartburn assessed retrospectively by the investigator. Classified by severity (none, mild, moderate, severe). Participants with severe heartburn","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":103,"n":248},"commonTop":[]}}}